NEW YORK (GenomeWeb News) – Bioinformatics software firm DNAStar said today it received a Phase II Small Business Innovation Research Grant in support of R&D aimed at expanding the company's sequence assembly and analysis software.

The grant from the National Human Genome Research Institute will be used by the Madison, Wis.-based firm to build out the capabilities of its software from broad research use to the clinical research market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.